- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MXW: N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}phenyl)methanesulfonamide(Non-covalent)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
ANP.2: 22 residues within 4Å:- Chain A: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, F.239, E.240, G.329, N.330, F.331, R.333
- Chain B: I.261
- Ligands: MXW.1, EDO.3, MG.5
23 PLIP interactions:23 interactions with chain A- Hydrogen bonds: A:G.28, A:T.29, A:L.30, A:K.32, A:R.94, A:G.199, A:S.200, A:G.201, A:G.223, A:E.240, A:N.330, A:N.330, A:F.331, A:R.333
- Water bridges: A:K.32, A:K.32, A:N.197, A:N.197, A:N.197, A:N.197, A:G.199
- Salt bridges: A:K.32
- pi-Stacking: A:F.239
ANP.7: 22 residues within 4Å:- Chain A: I.261
- Chain B: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, F.239, E.240, G.329, N.330, F.331, R.333
- Ligands: MXW.6, EDO.8, MG.10
24 PLIP interactions:24 interactions with chain B- Hydrogen bonds: B:G.28, B:T.29, B:L.30, B:K.32, B:R.94, B:G.199, B:S.200, B:G.201, B:G.223, B:E.240, B:N.330, B:N.330, B:F.331, B:R.333
- Water bridges: B:T.29, B:K.32, B:K.32, B:N.197, B:N.197, B:N.197, B:N.197, B:G.199
- Salt bridges: B:K.32
- pi-Stacking: B:F.239
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 6 residues within 4Å:- Chain A: L.30, T.69, I.71, R.94, F.95
- Ligands: ANP.2
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.94
- Water bridges: A:E.240
EDO.4: 5 residues within 4Å:- Chain A: D.265, Y.266, E.267, R.268
- Chain B: Y.127
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:D.265, A:E.267, A:R.268
- Water bridges: B:Y.127
EDO.8: 6 residues within 4Å:- Chain B: L.30, T.69, I.71, R.94, F.95
- Ligands: ANP.7
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.94
- Water bridges: B:E.240
EDO.9: 5 residues within 4Å:- Chain A: Y.127
- Chain B: D.265, Y.266, E.267, R.268
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.265, B:E.267, B:R.268
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Discovery of hPANK Activators with Improved Pharmacological Properties. To Be Published
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MXW: N-(4-{2-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-oxoethyl}phenyl)methanesulfonamide(Non-covalent)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Discovery of hPANK Activators with Improved Pharmacological Properties. To Be Published
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A